Skip to main content

Table 4 Association of HAART and other variables with renal function paramaters

From: HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon

 

eGFR

P-value

Serum creatinine

P-value

Serum albumin

P-value

Serum total protein

P-value

HAART

6.9 (0.79–59.5)

0.080

2.5 (0.94–6.43)

0.064

12.8 (2.74–59.57)

0.001

2.0 (0.92–4.37)

0.079

Adjusted for HAART + HAART/DOTS

4.6 (0.49–42.2)

0.181

2.6 (0.97–6.72)

0.058

0.58 (0.5-6–71)

0.664

2.1 (0.97–4.71)

0.060

Adjusted for HAART + HAART/DOTS + Age (>40 years)

3.5 (1.1–11.3)

0.036

1.1 (0.52–2.40)

0.775

0.36 (0.11–1.24)

0.107

1.7 (0.88–3.22)

0.113

Adjusted for HAART + HAART/DOTS + Age (>40 years) + Gender (female)

6.0 (1.41–25.61)

0.015

0.7 (0.35–1.63)

0.488

0.95 (0.34–2.67)

0.931

1.4 (0.75–2.74)

0.270

Adjusted for HAART + HAART/DOTS + Age (>40 years) + Gender (female) + BMI (≥25 kg/m2)

4.8 (1.48–15.35)

0.009

2.2 (1.0–4.85)

0.050

1.01 (0.31–3.27)

0.982

0.7 (0.35–1.59)

0.449

Adjusted for HAART + HAART/DOTS + Age (>40 years) + Gender (female) + BMI (≥25 kg/m2) + Hypertension

3.9 (0.56–26.63)

0.170

11.9 (3.32–42.54)

<0.001

1.42 (0.14–14.53)

0.770

6.0 (1.77–19.98)

0.004

  1. Key: BMI body mass index, DOTS Direct Observed Therapy, Short-course, HAART Highly Active Antiretroviral Therapy, Reference group participants on DOTS